Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Pollinex-R Ragweed vaccine
print preview
bookmark
share with colleague
General Information
Company
Allergy Therapeutics plc
Description
Subcutaneous ragweed allergy vaccine formulated with allergoids and tyrosine
Molecular Target
Mechanism of Action
Latest Stage of Development
Approved
Indication
Allergy
Partner
Paladin Labs Inc.
;
Takeda Pharmaceutical Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy